dual JAK1 JH2 pseudokinase/VPS34 inhibitors (Brigham Young University)

N/A

Report date: 2025/03/19 11:37:39
NME

Base Information

Drug Namedual JAK1 JH2 pseudokinase/VPS34 inhibitors (Brigham Young University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK1 inhibitorsPhosphatidylinositol 3-kinase catalytic subunit type 3 inhibitors
TargetsPhosphatidylinositol 3-kinase catalytic subunit type 3Tyrosine-protein kinase JAK1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBrigham Young University
China Registration ClassN/A

Develop Information

Active CompaniesBrigham Young University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A